Yat Sun Or
Fortuna: 5 M $ al 30/06/2026
Fortuna: 5 M $ al 30/06/2026
Yat Sun Or currently works at Enanta Pharmaceuticals, Inc., as CSO, Senior Vice President-Research & Development from 1999.
Dr. Or also formerly worked at Abbott Laboratories, as Principal and Schering-Plough Pharmaceuticals, as Member-Cardiovascular Drug Discovery Team.
Dr. Or received his doctorate degree in 1980 from The University of Chicago.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/02/2026 | 374.854 ( 1,29 % ) | 5 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/11/1999 |
| Empresas | Cargo | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Schering-Plough Pharmaceuticals | Portfolio Manager-Fixed Income | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Schering-Plough Pharmaceuticals |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.